Recombinant human monoclonal antibody TO human IL-1beta OF THE IGG1/K class
( DrugBank: - / KEGG DRUG: - )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 106 | Cryopyrin-associated periodic syndrome | 8 |
| 107 | Juvenile idiopathic arthritis | 29 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 108 | TNF receptor-associated periodic syndrome | 2 |
106. Cryopyrin-associated periodic syndrome
Clinical trials : 56 / Drugs : 27 - (DrugBank : 7) / Drug target genes : 4 - Drug target pathways : 47
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
107. Juvenile idiopathic arthritis
Clinical trials : 477 / Drugs : 232 - (DrugBank : 53) / Drug target genes : 66 - Drug target pathways : 160
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
108. TNF receptor-associated periodic syndrome
Clinical trials : 5 / Drugs : 5 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 43
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|